MEDIKARDAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDIKARDAL
Largest movements
- Current investments +€262,460
new in 2025: €262,460
- Cash -€148,908
down €148,908 (-61.0%), from €244,013 to €95,105
mainly Current investments (-€262,460) and Contributions, distributions and other (-€140,000)
- Intangible fixed assets -€4,500
down €4,500 (-20.0%), from €22,500 to €18,000
- Other debts +€85,055
up €85,055 (+31.1%), from €273,325 to €358,381
- Tax, wage and social debts +€12,436
up €12,436 (+239%), from €5,200 to €17,636
- Profit (loss) carried forward +€8,008
up €8,008 (+67.1%), from €11,928 to €19,936
- Gross operating margin +€62,202
up €62,202 (+42.0%), from €148,237 to €210,439
- Taxes +€24,132
up €24,132 (+85.3%), from €28,292 to €52,424
- Other operating charges -€4,797
down €4,797 (-90.1%), from €5,326 to €528
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €302,279 | €406,396 | +€104,117 | +34.4% |
| Fixed assets | 21/28 | €43,154 | €36,623 | -€6,531 | -15.1% |
| Intangible fixed assets | 21 | €22,500 | €18,000 | -€4,500 | -20.0% |
| Tangible fixed assets | 22/27 | €7,654 | €5,623 | -€2,031 | -26.5% |
| Plant, machinery and equipment | 23 | €2,188 | €1,763 | -€426 | -19.5% |
| Furniture and vehicles | 24 | €5,466 | €3,860 | -€1,606 | -29.4% |
| Financial fixed assets | 28 | €13,000 | €13,000 | = | 0.0% |
| Current assets | 29/58 | €259,125 | €369,773 | +€110,649 | +42.7% |
| Amounts receivable within one year | 40/41 | €9,309 | €10,247 | +€938 | +10.1% |
| Trade receivables | 40 | €2,601 | €3,539 | +€938 | +36.1% |
| Other amounts receivable | 41 | €6,708 | €6,708 | = | 0.0% |
| Current investments | 50/53 | - | €262,460 | +€262,460 | |
| Cash at bank and in hand | 54/58 | €244,013 | €95,105 | -€148,908 | -61.0% |
| Deferred charges and accrued income | 490/1 | €5,803 | €1,961 | -€3,841 | -66.2% |
| Total equity and liabilities | 10/49 | €302,279 | €406,396 | +€104,117 | +34.4% |
| Equity | 10/15 | €21,928 | €29,936 | +€8,008 | +36.5% |
| Contributions | 10/11 | €10,000 | €10,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €11,928 | €19,936 | +€8,008 | +67.1% |
| Amounts payable | 17/49 | €280,351 | €376,460 | +€96,109 | +34.3% |
| Amounts payable within one year | 42/48 | €280,351 | €376,460 | +€96,109 | +34.3% |
| Trade debts | 44 | €1,826 | €444 | -€1,381 | -75.7% |
| Suppliers | 440/4 | €1,826 | €444 | -€1,381 | -75.7% |
| Taxes, remuneration and social security | 45 | €5,200 | €17,636 | +€12,436 | +239% |
| Taxes | 450/3 | €5,200 | €17,636 | +€12,436 | +239% |
| Other amounts payable | 47/48 | €273,325 | €358,381 | +€85,055 | +31.1% |
| Remuneration, social security and pensions | 62 | -€64 | - | +€64 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,992 | €6,531 | +€539 | +9.0% |
| Other operating charges | 640/8 | €5,326 | €528 | -€4,797 | -90.1% |
| Gross operating margin | 9900 | €148,237 | €210,439 | +€62,202 | +42.0% |
| Operating profit (loss) | 9901 | €136,983 | €203,379 | +€66,396 | +48.5% |
| Financial income | 75/76B | - | €502 | +€502 | |
| Recurring financial income | 75 | - | €502 | +€502 | |
| Financial charges | 65/66B | €2,790 | €3,450 | +€659 | +23.6% |
| Recurring financial charges | 65 | €2,790 | €3,450 | +€659 | +23.6% |
| Profit (loss) for the period before taxes | 9903 | €134,193 | €200,432 | +€66,239 | +49.4% |
| Income taxes | 67/77 | €28,292 | €52,424 | +€24,132 | +85.3% |
| Profit (loss) for the period | 9904 | €105,901 | €148,008 | +€42,107 | +39.8% |
| Profit (loss) for the period to be appropriated | 9905 | €105,901 | €148,008 | +€42,107 | +39.8% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.